Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy

Adoptive cell therapy with chimeric antigen receptor (CAR)-engineered T cells (CAR-Ts) has emerged as an innovative immunotherapy for hematological cancer treatment. However, the limited effect on solid tumors, complex processes, and excessive manufacturing costs remain as limitations of CAR-T thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seungyong, Lee, Pyunghwajun, Han, Jieun, Kim, Se-Na, Lim, Jaesung, Park, Dae-Hwan, Paik, Taejong, Min, Junhong, Park, Chun Gwon, Park, Wooram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983528/
https://www.ncbi.nlm.nih.gov/pubmed/36867402
http://dx.doi.org/10.1007/s13770-022-00515-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983528/
https://www.ncbi.nlm.nih.gov/pubmed/36867402
http://dx.doi.org/10.1007/s13770-022-00515-8

Ejemplares similares